Evolve Global Healthcare Enhanced Yield Fund Fundamental Analysis
Evolve Global Healthcare Enhanced Yield Fund Fundamental Analysis
Evolve Global Healthcare Enhanced Yield Fund (LIFE.TO) shows weak financial fundamentals with a PE ratio of 24.28, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze LIFE.TO's fundamental strength across five key dimensions:
Efficiency Score
WeakLIFE.TO struggles to generate sufficient returns from assets.
Valuation Score
ModerateLIFE.TO shows balanced valuation metrics.
Growth Score
ModerateLIFE.TO shows steady but slowing expansion.
Financial Health Score
WeakLIFE.TO carries high financial risk with limited liquidity.
Profitability Score
WeakLIFE.TO struggles to sustain strong margins.
Key Financial Metrics
Is LIFE.TO Expensive or Cheap?
P/E Ratio
LIFE.TO trades at 24.28 times earnings. This indicates a fair valuation.
Dividend Yield
The dividend yield of 12.79% provides an income stream to investors.
How Well Does LIFE.TO Make Money?
No data available.
Following the Money - Real Cash Generation
No data available.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
N/A
vs 25 benchmark
Current Ratio
Current assets to current liabilities
N/A
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
N/A
vs 25 benchmark
ROA
Return on assets percentage
N/A
vs 25 benchmark
ROCE
Return on capital employed
N/A
vs 25 benchmark
How LIFE.TO Stacks Against Its Sector Peers
| Metric | LIFE.TO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 21.29 | N/A |
| ROE | N/A | 634.00% | N/A |
| Net Margin | N/A | -906.00% (disorted) | N/A |
| Debt/Equity | N/A | 1.51 | N/A |
| Current Ratio | N/A | 924.12 | N/A |
| ROA | N/A | -857.00% (disorted) | N/A |
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Evolve Global Healthcare Enhanced Yield Fund's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical